Posaconazole Tablet, Delayed Release
Product Images NDC 70748-258

2 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 70748-258). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Posaconazole (32b94024 0ca5 4767 9c72 B1f8ec8699ae 01)

Posaconazole (32b94024 0ca5 4767 9c72 B1f8ec8699ae 01)
Chemical structure of posaconazole, the active ingredient in POSACONAZOLE 100 mg delayed-release tablets by Lupin Pharmaceuticals. The diagram shows the molecular arrangement of atoms and bonds specific to posaconazole.*
FDA Label Image

Image (32b94024 0ca5 4767 9c72 B1f8ec8699ae 02)

Image (32b94024 0ca5 4767 9c72 B1f8ec8699ae 02)
Posaconazole Delayed-Release Tablets 100 mg oral dosage form packaging label from Lupin Pharmaceuticals, Inc. The label indicates 60 tablets per package, prescribing information, storage instructions, and a warning that Posaconazole delayed-release tablets are not interchangeable with Noxafil oral suspension. The label includes the product NDC 70748-258-07.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.